Last summer, when regenerative medicine company Stem Cell Theranostics went through the StartX accelerator program at Stanford University along with one other biotech company, the team members realized that many aspects of their experience were much different than those of the other companies. For example, they weren’t moving as quickly as the other companies, and they faced regulatory hurdles that the others didn’t have to deal with.
Several months later, one of Stem Cell Theranostic’s student founders, Divya Nag, became the founder and CEO of the healthcare-focused accelerator track StartX Med, which launched its first class this summer comprising 11 health IT, medical device and biotech companies. The six-month track provides select students and faculty with education, community and mentorship for their startups.